Stock listing

IMUX Stock Price, News, Filings & Events — Immunic, Inc.

Selected listing: IMUX · BOATS · USD · US

This page tracks Immunic, Inc.'s IMUX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMUX:BOATS. IMUX:BOATS is the stock-level entry point for investors researching Immunic, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immunic, Inc. is a public company traded under the ticker IMUX in the American market. The company has a market capitalization of approximately $182.4 million. Immunic focuses on developing innovative therapies for autoimmune diseases.

IMUX:BOATSUSDUSUpdated August 31, 2026
Immunic, Inc. logo
Ticker
IMUX:BOATS
Asset type
Stock
Market cap
$210.1M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
BOATS
Currency
USD

Immunic, Inc. IMUX:BOATS stock context

This page tracks Immunic, Inc.'s IMUX:BOATS listing on BOATS in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IMUX:BOATS. IMUX:BOATS is the stock-level entry point for investors researching Immunic, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Immunic, Inc. is a public company traded under the ticker IMUX in the American market. The company has a market capitalization of approximately $182.4 million. Immunic focuses on developing innovative therapies for autoimmune diseases.

Latest news from Immunic, Inc.

All Immunic, Inc. news →

Immunic, Inc. earnings calls

Research Immunic, Inc.

Alternate listings